60 related articles for article (PubMed ID: 24820046)
21. Transpupillary thermotherapy for the treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration.
Tranos P; Singh M; Peter NM; Dhir L; Kon C; Rassam S
Acta Ophthalmol Scand; 2004 Oct; 82(5):585-90. PubMed ID: 15453858
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study.
Costa RA; Jorge R; Calucci D; Cardillo JA; Melo LA; Scott IU
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4569-78. PubMed ID: 17003454
[TBL] [Abstract][Full Text] [Related]
23. Subthreshold transpupillary thermotherapy for subfoveal occult choroidal neovascularization secondary to age-related macular degeneration.
Midena E; Pilotto E; Radin PP; Convento E
Semin Ophthalmol; 2004; 19(1-2):25-8. PubMed ID: 15590531
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
[TBL] [Abstract][Full Text] [Related]
25. Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2.
Stevenson MR; Hart PM; Chakravarthy U; Mackenzie G; Bird AC; Owens SL; Chisholm IH; Hall V; Houston RF; McCulloch DW; Plowman N
Br J Ophthalmol; 2005 Aug; 89(8):1045-51. PubMed ID: 16024863
[TBL] [Abstract][Full Text] [Related]
26. Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation.
Moutray T; Alarbi M; Mahon G; Stevenson M; Chakravarthy U
Br J Ophthalmol; 2008 Mar; 92(3):361-4. PubMed ID: 18303157
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.
Yamamoto I; Rogers AH; Reichel E; Yates PA; Duker JS
Br J Ophthalmol; 2007 Feb; 91(2):157-60. PubMed ID: 16870653
[TBL] [Abstract][Full Text] [Related]
28. Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study.
Midena E; Radin PP; Pilotto E; Ghirlando A; Convento E; Varano M
Semin Ophthalmol; 2004; 19(1-2):55-61. PubMed ID: 15590535
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.
Ruiz-Moreno JM; Montero JA; Gomez-Ulla F; Ares S
Br J Ophthalmol; 2009 Apr; 93(4):448-51. PubMed ID: 19091851
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration.
Marcus DM; Sheils WC; Young JO; McIntosh SB; Johnson MH; Alexander J; Samy CN
Br J Ophthalmol; 2004 Jan; 88(1):114-9. PubMed ID: 14693787
[TBL] [Abstract][Full Text] [Related]
31. Low-dose proton beam therapy for circumscribed choroidal hemangiomas.
Frau E; Rumen F; Noel G; Delacroix S; Habrand JL; Offret H
Arch Ophthalmol; 2004 Oct; 122(10):1471-5. PubMed ID: 15477458
[TBL] [Abstract][Full Text] [Related]
32. Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial.
Ciulla TA; Danis RP; Klein SB; Malinovsky VE; Soni PS; Pratt LM; Pugh NO; Morphis JG; Bloch C; Cameron J
Am J Ophthalmol; 2002 Dec; 134(6):905-6. PubMed ID: 12470761
[TBL] [Abstract][Full Text] [Related]
33. Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: treatment techniques and preliminary results.
Yonemoto LT; Slater JD; Friedrichsen EJ; Loredo LN; Ing J; Archambeau JO; Teichman S; Moyers MF; Blacharski PA; Slater JM
Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):867-71. PubMed ID: 8960515
[TBL] [Abstract][Full Text] [Related]
34. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma.
Gragoudas ES; Lane AM; Regan S; Li W; Judge HE; Munzenrider JE; Seddon JM; Egan KM
Arch Ophthalmol; 2000 Jun; 118(6):773-8. PubMed ID: 10865313
[TBL] [Abstract][Full Text] [Related]
35. [Choroid neovascularization in senile macular degeneration. 1 hear follow-up after radiotherapy].
Roesen B; Scheider A; Kiraly A; Gofferjé MA; Feldmann HJ
Ophthalmologe; 1998 Jul; 95(7):461-5. PubMed ID: 9738374
[TBL] [Abstract][Full Text] [Related]
36. Radiation maculopathy after proton beam irradiation for choroidal melanoma.
Guyer DR; Mukai S; Egan KM; Seddon JM; Walsh SM; Gragoudas ES
Ophthalmology; 1992 Aug; 99(8):1278-85. PubMed ID: 1325044
[TBL] [Abstract][Full Text] [Related]
37. Physiologic and radiographic evidence of the distal edge of the proton beam in craniospinal irradiation.
Krejcarek SC; Grant PE; Henson JW; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):646-9. PubMed ID: 17449195
[TBL] [Abstract][Full Text] [Related]
38. External beam radiation therapy for CNV.
Beaumont P; Chang A
Ophthalmology; 1998 Oct; 105(10):1792-3; author reply 1793-4. PubMed ID: 9787340
[No Abstract] [Full Text] [Related]
39. Visual-field deficits associated with proton beam irradiation for parapapillary choroidal melanoma.
Park SS; Walsh SM; Gragoudas ES
Ophthalmology; 1996 Jan; 103(1):110-6. PubMed ID: 8628541
[TBL] [Abstract][Full Text] [Related]
40. [Radiotherapy of age-related macular degeneration. Case reports].
Puchalska-Niedbał L; Sylwestrzak Z; Jarema A
Klin Oczna; 2008; 110(1-3):82-7. PubMed ID: 18669092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
